Jump Trading’s Palvella Therapeutics PVLA Stock Holding History

Jump Trading’s Portfolio PVLA Stock Details PVLA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q3	–	Sell	-126	Closed	-$51K	–	580
2018 Q2	$51K	Buy	+126	New	+$60K	﹤0.01%	363

Other funds holding PVLA

BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

TCM

Tekla Capital Management Boston, Massachusetts $2.56B AUM 18.15% 1-Year Est. Return

ACM

Aquilo Capital Management San Francisco, California $55.8M AUM 41.76% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Prosight Management Dallas, Texas $610M AUM 40.86% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Jump Trading's PVLA Position: Q3 2018 in Review

Jump Trading sold out of Palvella Therapeutics (PVLA) in Q3 2018, closing a stake of 126 shares — an estimated $51K sold.

Jump Trading first reported a position in PVLA in Q2 2018 and held it in 1 quarter. The position peaked at $51K in Q2 2018. 105 funds tracked by Wall St. Rank hold PVLA as of Q3 2018.

Jump Trading reported no remaining Palvella Therapeutics position as of Q3 2018 after selling out during the quarter.
Jump Trading sold 126 Palvella Therapeutics shares in Q3 2018, an estimated $51K.
Jump Trading first reported a position in Palvella Therapeutics in Q2 2018 and held it in 1 quarter.
Jump Trading's Palvella Therapeutics position peaked at $51K in Q2 2018.
105 funds tracked by Wall St. Rank held Palvella Therapeutics as of Q3 2018.

Based on Jump Trading's 13F filing for Q3 2018, filed 14 Nov 2018.